87 related articles for article (PubMed ID: 17558835)
21. [Evaluation of radioiodine 131I treatment in Graves' disease patients with mild orbitopathy].
Bałdys-Waligórska A; Stefańska A; Gołkowski F; Sokołowski G; Hubalewska-Dydejczyk A
Przegl Lek; 2009; 66(4):166-9. PubMed ID: 19708504
[TBL] [Abstract][Full Text] [Related]
22. Exophthalmometer readings in patients with Graves' eye disease.
Frueh BR; Musch DC; Garber FW
Ophthalmic Surg; 1986 Jan; 17(1):37-40. PubMed ID: 3754041
[TBL] [Abstract][Full Text] [Related]
23. Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission.
Eckstein AK; Lax H; Lösch C; Glowacka D; Plicht M; Mann K; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2007 Oct; 67(4):607-12. PubMed ID: 17880407
[TBL] [Abstract][Full Text] [Related]
24. Association of the interleukin (IL)-16 gene polymorphisms with Graves' disease.
Gu XJ; Cui B; Zhao ZF; Chen HY; Li XY; Wang S; Ning G; Zhao YJ
Clin Immunol; 2008 Jun; 127(3):298-302. PubMed ID: 18394967
[TBL] [Abstract][Full Text] [Related]
25. Graves-Basedow disease goiter: a model of Bax-Bcl2 regulated apoptosis.
Labat-Moleur F; Chabre O; Guillermet C; Chaffanjon P; Blumet-Rondeu F; Bauchet A; Franc B; Brambilla E; Bachelot I; Dumont JE; Negoescu A
Thyroid; 1999 May; 9(5):483-92. PubMed ID: 10365680
[TBL] [Abstract][Full Text] [Related]
26. [Management of Graves' orbitopathy: evidence-based recommendations].
Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
[TBL] [Abstract][Full Text] [Related]
27. Endoscopic orbital decompression for optic neuropathy in thyroid ophthalmopathy.
Tang IP; Prepageran N; Subrayan V; Tajunisah I
Med J Malaysia; 2008 Oct; 63(4):337-8. PubMed ID: 19385499
[TBL] [Abstract][Full Text] [Related]
28. Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy.
Eckstein AK; Lösch C; Glowacka D; Schott M; Mann K; Esser J; Morgenthaler NG
Br J Ophthalmol; 2009 Aug; 93(8):1052-6. PubMed ID: 19221109
[TBL] [Abstract][Full Text] [Related]
29. Long-term results of surgical treatment in Graves' disease orbitopathy. Is there a correlation between the extent of thyroidectomy and the course of orbithopathy?
Maurer E; Dănilă R; Dominguez E; Osei-Agymang T; Zielke A; Hassan I
Chirurgia (Bucur); 2008; 103(3):291-5. PubMed ID: 18717277
[TBL] [Abstract][Full Text] [Related]
30. Results and predictability of fat-removal orbital decompression for disfiguring graves exophthalmos in an Asian patient population.
Wu CH; Chang TC; Liao SL
Am J Ophthalmol; 2008 Apr; 145(4):755-9. PubMed ID: 18241831
[TBL] [Abstract][Full Text] [Related]
31. Changes in the orbital tissues and muscles dysthyroid ophthalmopathy.
Bleeker GM
Eye (Lond); 1988; 2 ( Pt 2)():193-7. PubMed ID: 3058525
[TBL] [Abstract][Full Text] [Related]
32. Soluble CD40 and its ligand CD154 in patients with Graves' ophthalmopathy during combined therapy with corticosteroids and teleradiotherapy.
Myśliwiec J; Waligórski D; Nikołajuk A; Górska M
Adv Med Sci; 2007; 52():104-8. PubMed ID: 18217399
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of open-angle glaucoma, glaucoma suspect, and ocular hypertension in thyroid-related immune orbitopathy.
Behrouzi Z; Rabei HM; Azizi F; Daftarian N; Mehrabi Y; Ardeshiri M; Mohammadpour M
J Glaucoma; 2007; 16(4):358-62. PubMed ID: 17570998
[TBL] [Abstract][Full Text] [Related]
34. The Pro 12 Ala PPAR gamma gene polymorphism: possible modifier of the activity and severity of thyroid-associated orbitopathy (TAO).
Alevizaki M; Mantzou E; Cimponeriu A; Saltiki K; Philippou G; Wiersinga W
Clin Endocrinol (Oxf); 2009 Mar; 70(3):464-8. PubMed ID: 18624999
[TBL] [Abstract][Full Text] [Related]
35. Unique properties of orbital connective tissue underlie its involvement in Graves' disease.
Smith TJ
Minerva Endocrinol; 2003 Sep; 28(3):213-22. PubMed ID: 14605603
[TBL] [Abstract][Full Text] [Related]
36. The influence of previous orbital irradiation on the outcome of rehabilitative decompression surgery in graves orbitopathy.
Baldeschi L; MacAndie K; Koetsier E; Blank LE; Wiersinga WM
Am J Ophthalmol; 2008 Mar; 145(3):534-540. PubMed ID: 18191092
[TBL] [Abstract][Full Text] [Related]
37. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients.
Esteghamati A; Khalilzadeh O; Mobarra Z; Anvari M; Tahvildari M; Amiri HM; Rashidi A; Solgi G; Parivar K; Nikbin B; Amirzargar A
Eur J Intern Med; 2009 Jul; 20(4):424-8. PubMed ID: 19524188
[TBL] [Abstract][Full Text] [Related]
38. Proliferating potential and apoptosis in the development of secondary hyperparathyroidism: a study based on Ki-67 immunohistochemical staining and the terminal dUTP nick-end labeling assay.
Wada Y; Kunimura T; Sato S; Hisayuki T; Sato M; Imataka H; Yamashita N; Akizawa T; Moroboshi T
Ther Apher Dial; 2008 Aug; 12(4):319-28. PubMed ID: 18789120
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of alpha-fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma.
Mitsuhashi N; Kobayashi S; Doki T; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Nozawa S; Furukawa K; Takeuchi D; Suda K; Miura S; Miyazaki M
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e189-97. PubMed ID: 18466288
[TBL] [Abstract][Full Text] [Related]
40. The plastic surgeon and Graves disease.
Chiarelli A
Ann Ital Chir; 2004; 75(3):315-9. PubMed ID: 15605519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
